Journal of Virus Eradication 2016; 2 (Supplement 4): 1–6
Review
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
Policy Brief, Updated in March 2017
The WHO Global Burden of Disease (GBD) study measures the burden of
disease using the disability-adjusted life year metric (DALY). The DALY metric
was developed to assess the burden of disease consistently across diseases,
risk factors and regions. A consistent and comparative description of the ...burden
of diseases and injuries and the risk factors that cause them is important as it
can inform health decision-making and health care planning.
more
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...; violence; lack of community empowerment and other violations of human rights. These sociostructural factors limit access to health services, constrain how these services are
delivered and diminish their effectiveness.
more
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions... into their ongoing monitoring efforts and to report comprehensive national data through the Global AIDS Monitoring (GAM) process. In this way they will contribute to improving understanding of the global response to the HIV epidemic, including progress that has been made towards achieving the commitments and global targets set out in the new United Nations Political Declaration on HIV and AIDS: Ending Inequalities and Getting on Track to End AIDS by 2030, adopted in June 2021, and the linked Sustainable Development Goals.
more
These guidelines have been developed in simple, user-friendly language and they explain the procedures for patients’ access to and the safe management of Schedule I and II drugs that are necessary for the treatment and relief of moderate to severe pain. They provide both procedures for acquisition... and information on records or documents that are necessary to ensure that these medicines are made available and accessible to patients across the entire health care delivery system (i.e. from tertiary institutions to primary level) and ensuring prevention of illicit non-medical use.
more
Handout presentations in PDF for illustrating lectures
Accessed May 2014
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
Dieser MedGuide erleichtert die Diagnostik psychischer Störungen bei fremdsprachigen Patienten.
Es wurden die wichtigsten Punkte einer psychiatrischen und psychotherapeutischen Anamnese zu beruecksichtigen. Dabei legten sie einen besonderen Schwerpunkt auf Fragen zur posttraumatischen Belastungsst...örung / PTBS und Dissoziation.
Wichtig war ebenfalls die Abfrage von Migrationsaspekten wie Integration und von kulturellen Besonderheiten.
Dieser „gruene“ MedGuide bietet somit eine sehr umfassende Sammlung von Fragen und Antworten, die in der medizinischen Versorgung von psychisch erkrankten Menschen wichtig sind.
Zusatztipp: Der blaü MedGuide „Allgemeinmedizin“ dient als Grundlage für die somatische Diagnostik auch bei psychischen Störungen
Der Guide kann ab April 2018 für 39.90 € erworben werden.
more
Informe mundial sobre las drogas
Essential Medicines and Health Products Information Portal
Rapport mondial sur les drogues 2018